Showing 3571-3580 of 8741 results for "".
- Candela Launches the All-New Profound Matrix Systemhttps://practicaldermatology.com/news/candela-launches-the-all-new-profound-matrix-system/2461544/Candela is rolling out the all-new Profound Matrix system. This multi-application system features the Sublime, Sublative radiofrequency (RF), and all-new Matrix Pro applicators. The Sublime and Sublative RF applicators deliver bipolar RF treatments that improve the appearance of fine li
- New Biomarkers May Help Advance Melanoma Detectionhttps://practicaldermatology.com/news/new-biomarkers-may-help-advance-melanoma-detection/2461539/New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia. “Melanomas exhibit a wide range of sizes, shapes and growth, which can resemble numerous benign and other malignant skin lesions,&
- Daniel Hopkins Named New CEO at AlumierMDhttps://practicaldermatology.com/news/daniel-hopkins-named-new-ceo-at-alumiermd/2461537/Daniel Hopkins is AlumierMD’s new Chief Executive Officer. With more than a decade of experience in the aesthetic sector, Mr. Hopkins is prepared to take AlumierMD's commitment to the global aesthetic community through its next exciting phase of growth. Mr. Hopkins
- Merz Aesthetics, NWSL’s North Carolina Courage Expand Partnershiphttps://practicaldermatology.com/news/merz-aesthetics-partners-with-wsls-north-carolina-courage-to-fuel-confidence-on-and-off-field/2461532/Merz Aesthetics is expanding its sponsorship of the North Carolina Courage, two-time champions of the National Women’s Soccer League (NWSL). “This partnership is so meaningful for us at Merz Aesthetics,” says Patrick Urban, North America President, in
- Mount Sinai Researchers Awarded $12 Million NIH Grant to Create a Center to Study Causes of Atopic Dermatitis and Food Allergyhttps://practicaldermatology.com/news/mount-sinai-researchers-awarded-12-million-nih-grant-to-create-a-center-to-study-causes-of-atopic-dermatitis-and-food-allergy/2461520/Mount Sinai researchers have been awarded $12 million over 5 years by the National Institutes of Health (NIH) to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis, according to a news release. The Systems Biology of Early Ato
- Twenty New Products Earn NPF Seal of Recognitionhttps://practicaldermatology.com/news/twenty-new-products-earn-npf-seal-of-recognition/2461512/Twenty new products have earned the National Psoriasis Foundation’s Seal of Recognition. Each of these 20 products passed the same rigorous application, review, and approval process as the other 45 products that comprise the
- La Roche Posay Celebrates Second Annual National HA Day on Jan. 21, 2023https://practicaldermatology.com/news/la-roche-posay-celebrates-second-annual-national-ha-day-on-jan-21-2023/2461510/La Roche-Posay is ringing in its second annual National Hyaluronic Acid Day on January 21st. To celebrate National Hyaluronic Acid Day, the brand is offering 20% off on orders of $65 or more on
- Sun Pharma Launches New AH-ha! It’s Acne Hormones Campaignhttps://practicaldermatology.com/news/sun-pharma-launches-new-ah-ha-its-acne-hormones-campaign/2461509/Sun Pharmaceutical Industries, Inc, is launching "AH-ha! It's Acne Hormones," an awareness campaign featuring Sandra Lee, MD (AKA TLC's "Dr. Pimple Popper"). The campaign is designed to spotlight hormones as
- Simple Laser Treatments May Help Prevent Nonmelanoma Skin Cancerhttps://practicaldermatology.com/news/simple-laser-treatments-may-help-prevent-nonmelanoma-skin-cancer/2461508/Nonablative fractional lasers treatments may help prevent basal cell carcinoma and squamous cell carcinoma, a new study suggests. Nonablative fractional lasers (NAFL) are currently used to treat scars, sun-damaged skin, age spots, and more; however, their effectiveness for pre
- New Guidance Issued on Treating Metastatic Melanoma During COVID-19https://practicaldermatology.com/news/new-guidance-issued-on-treating-metastatic-melanoma-during-covid-19/2461497/Metastatic melanoma patients taking systemic therapy should stay on treatment whenever possible, even during Covid-19 pandemic. This is the main takeaway from new research paper in Oncotarget's